Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dianthus Therapeutics, Inc. /DE/ | CEO AND PRESIDENT, Director | Stock Option (Right to Buy) | 243K | May 23, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | CEO AND PRESIDENT, Director |
DNTH | Dianthus Therapeutics, Inc. /DE/ | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | CEO AND PRESIDENT, Director |
MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 0 | $0 | 3 | Sep 13, 2023 | CEO and President, Director |